BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright: ©Author(s) 2026.
World J Clin Pediatr. Sep 9, 2026; 15(3): 120927
Published online Sep 9, 2026. doi: 10.5409/wjcp.120927
Table 1 Cholesterol, triglycerides and high-density lipoproteins levels at different time points after asparaginase treatment of patient 1
Patient 1Reference intervalBefore PEG-ASP therapyPEG-ASP therapy
Day 7
Day 14
Day 21
Day 28
CHOL (mmol/L)3.10-5.203.1615.9017.802.295.50
TG (mmol/L)0.00-1.691.06NA60.0042.106.08
HDL (mmol/L)1.17-1.551.670.311.441.311.89


Write to the Help Desk